Basis: Trailing twelve months (TTM). Source: stored company filings and market data; unavailable inputs remain N/A.
Is the earnings per share (EPS) high or low?
The earnings per share (EPS) of -0.13 is 99% above its 5-year average of -8.99, near the high end of its 5-year range (-27.30–-0.13).
96.15% above its 12-month average of -3.38.
Reported quarterly EPS; no daily interpolation. Q2 FY2026 (2026-06-30): -0.90.
EPS growth vs the same fiscal quarter in the prior fiscal year, last 33 comparable quarters.
EARNINGS PER SHARE (EPS)
-0.13
EARNINGS PER SHARE (EPS) AVG TTM
-3.38
EARNINGS PER SHARE (EPS) AVG 3Y
-5.70
EARNINGS PER SHARE (EPS) AVG 5Y
-8.99
EARNINGS PER SHARE (EPS) AVG 10Y
N/A
EARNINGS PER SHARE (EPS) AVG 15Y
N/A
EARNINGS PER SHARE (EPS) AVG 20Y
N/A
CURRENT VS TTM AVG
+96.15%
CURRENT VS 3Y AVG
+97.72%
CURRENT VS 5Y AVG
+98.55%
CURRENT VS 10Y AVG
N/A
CURRENT VS 15Y AVG
N/A
CURRENT VS 20Y AVG
N/A
Dianthus Therapeutics, Inc.
Market Cap
$4.92B
Earnings Per Share (EPS)
-0.13
TTM Avg
-3.38
3Y Avg
-5.70
5Y Avg
-8.99
Market Cap
$5.02B
Earnings Per Share (EPS)
0.62
TTM Avg
-0.43
3Y Avg
-0.91
5Y Avg
-0.91
Market Cap
$4.81B
Earnings Per Share (EPS)
-3.43
TTM Avg
-1.80
3Y Avg
-1.89
5Y Avg
-2.15
Market Cap
$4.78B
Earnings Per Share (EPS)
-0.41
TTM Avg
-0.74
3Y Avg
-1.01
5Y Avg
-1.11
Market Cap
$5.11B
Earnings Per Share (EPS)
-0.95
TTM Avg
-0.56
3Y Avg
-0.99
5Y Avg
-0.97
Market Cap
$5.20B
Earnings Per Share (EPS)
-3.31
TTM Avg
-2.88
3Y Avg
-2.49
5Y Avg
-2.72
Market Cap
$5.20B
Earnings Per Share (EPS)
2.42
TTM Avg
2.12
3Y Avg
1.80
5Y Avg
1.31
Market Cap
$5.27B
Earnings Per Share (EPS)
-2.31
TTM Avg
-2.18
3Y Avg
-2.26
5Y Avg
-2.81
Market Cap
$5.35B
Earnings Per Share (EPS)
0.85
TTM Avg
1.12
3Y Avg
0.90
5Y Avg
0.76
| NAME | MARKET CAP | EARNINGS PER SHARE (EPS) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| Dianthus Therapeutics, Inc. (DNTH) | $4.92B | -0.13 | -3.38 | -5.70 | -8.99 |
| BillionToOne, Inc. (BLLN)vs › | $5.02B | 0.62 | -0.43 | -0.91 | -0.91 |
| Definium Therapeutics, Inc. (DFTX)vs › | $4.81B | -3.43 | -1.80 | -1.89 | -2.15 |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.78B | -0.41 | -0.74 | -1.01 | -1.11 |
| Erasca, Inc. (ERAS)vs › | $5.11B | -0.95 | -0.56 | -0.99 | -0.97 |
| Scholar Rock Holding Corporation (SRRK)vs › | $5.20B | -3.31 | -2.88 | -2.49 | -2.72 |
| Merit Medical Systems, Inc. (MMSI)vs › | $5.20B | 2.42 | 2.12 | 1.80 | 1.31 |
| Cogent Biosciences, Inc. (COGT)vs › | $5.27B | -2.31 | -2.18 | -2.26 | -2.81 |
| Doximity, Inc. (DOCS)vs › | $5.35B | 0.85 | 1.12 | 0.90 | 0.76 |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.50B | -1.42 | -1.45 | -1.45 | -1.45 |
Trailing EPS (TTM)
$-0.13
Forward EPS (Est.)
$-3.79
P/E Ratio
N/A
Formula: EPS = Net Income / Weighted Average Shares Outstanding
Why EPS matters:
EPS (Earnings Per Share) represents the portion of a company's profit allocated to each outstanding share. Higher EPS indicates greater profitability on a per-share basis.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | EARNINGS PER SHARE (EPS) |
|---|---|
| 2025-12-31 | -4.20 |
| 2024-12-31 | -2.55 |
| 2023-12-31 | -8.45 |
| 2022-12-31 | -7.60 |
| 2021-12-31 | -3.82 |
| 2020-12-31 | -27.30 |
| 2019-12-31 | -33.18 |
| 2018-12-31 | -27.62 |
| 2017-12-31 | -16.05 |
| 2016-12-31 | -4.27 |
